About Click Therapeutics
Click Therapeutics is a company based in New York (United States) founded in 2012 by Wei Kiddy Zhou and David Benshoof Klein. Click Therapeutics has raised $180.32 million across 15 funding rounds from investors including SVB, Dassault Systems and HHS. Click Therapeutics offers products and services including Click SE and Prescription Digital Therapeutics. Click Therapeutics operates in a competitive market with competitors including Mindoula, Woebot Health, Limbix, PursueCare and Healios, among others.
- Headquarter New York, United States
- Founders Wei Kiddy Zhou, David Benshoof Klein
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Click Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$180.32 M (USD)
in 15 rounds
-
Latest Funding Round
$50 M (USD), Series D
Apr 09, 2026
-
Investors
SVB
& 13 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Click Therapeutics
Click Therapeutics offers a comprehensive portfolio of products and services, including Click SE and Prescription Digital Therapeutics.
Combines software with pharmacotherapy for improved clinical outcomes
Software applications for treating diseases like migraine and depression
People of Click Therapeutics
Unlock access to complete
Funding Insights of Click Therapeutics
Click Therapeutics has successfully raised a total of $180.32M across 15 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Click Therapeutics
Click Therapeutics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Dassault Systems and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Growth-stage US tech companies are funded by Health Catalyst Capital.
|
Locked | Locked | Locked | |
|
Life-Sciences focused Early stage Corporate VC Firm investing in the US
|
Locked | Locked | Locked |
Investor details for Click Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Click Therapeutics
Investment portfolio details for Click Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Click Therapeutics
Detailed financials for Click Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Click Therapeutics Comparisons
Peer comparison for Click Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Click Therapeutics
Click Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mindoula, Woebot Health, Limbix, PursueCare and Healios, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Virtual care management for behavioral health is provided by Mindoula.
|
|
| Locked | Locked | Locked |
AI-powered chat-based mental wellness tools are developed.
|
|
| Locked | Locked | Locked |
VR-based exposure therapy for anxiety and phobias is provided.
|
|
| Locked | Locked | Locked |
Addiction treatment is delivered via mobile app teleconsultations.
|
|
| Locked | Locked | Locked |
Digital therapeutics for mental and physical illnesses are provided online.
|
Detailed competitors of Click Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Click Therapeutics
Complete news archive for Click Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Click Therapeutics
Click Therapeutics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Click Therapeutics is headquartered in New York, United States. It is registered at New York, New York, United States.
David Benshoof Klein is the current CEO of Click Therapeutics. They have also founded this company.
Click Therapeutics is a funded company, having raised a total of $180.32M across 15 funding rounds to date.
Founded in 2012 and headquartered in New York, United States, Click Therapeutics operates in the digital health sector. Mobile applications are developed to address brain disorders and neuropsychiatric conditions, including smoking cessation, Alzheimers disease, ADHD, and traumatic brain injury. Daily activities are tracked by patients through the platform, which facilitates behavior and cognitive modifications while enabling connections to care teams.
Click Therapeutics's top competitors include PursueCare, Woebot Health and Mindoula.
Click Therapeutics offers Click SE and Prescription Digital Therapeutics.
Click Therapeutics has 14 investors. Key investors include SVB, Dassault Systems, HHS, Revelation Partners, and HIG BioHealth Partners.